Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis

Probiotics may correct intestinal dysbiosis and proinflammatory conditions in patients with liver cirrhosis.

• Publication year

  2016

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2016-09-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/apt.13788PMID 27593544PMCID 5053220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel Strategies in the Prevention and Treatment of Urinary Tract Infections

  2016cited by this paper
• Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.

  2015cited by this paper
• Immunosuppression and probiotics: are they effective and safe?

  2015cited by this paper
• Endotoxinmessung bei Leberzirrhose: Ein Methodenvergleich

  2015cited by this paper
• Impaired innate immune response of leukocytes from ascitic fluid of patients with spontaneous bacterial peritonitis

  2015cited by this paper
• Rapid killing of Capnocytophaga canimorsus and Capnocytophaga cynodegmi by human whole blood and serum is mediated via the complement system

  2015cited by this paper
• Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

  2015cited by this paper
• The Liver May Act as a Firewall Mediating Mutualism Between the Host and Its Gut Commensal Microbiota

  2014cited by this paper
• Intestinal permeability – a new target for disease prevention and therapy

  2014cited by this paper
• Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.

  2014cited by this paper
• The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90‐day and 1‐year mortality

  2014cited by this paper
• Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.

  2014cited by this paper
• Influence of the Multispecies Probiotic Ecologic ® BARRIER on Parameters of Intestinal Barrier Function

  2014cited by this paper
• Circulating neutrophil dysfunction in acute liver failure

  2013cited by this paper
• Research confuses me: what is the difference between case-control and cohort studies in quantitative research?

  2013cited by this paper
• Altered Functionality of Anti-Bacterial Antibodies in Patients with Chronic Hepatitis C Virus Infection

  2013cited by this paper
• Measuring the global burden of disease.

  2013cited by this paper
• Endotoxin Priming of Neutrophils Requires Endocytosis and NADPH Oxidase-dependent Endosomal Reactive Oxygen Species*

  2012cited by this paper
• Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial

  2012cited by this paper
• Infectious Complications of Acute and Chronic Liver Disease

  2012cited by this paper
• Evidence of neutrophil functional defect despite inflammation in stable cirrhosis.

  2011cited by this paper
• Recommendations for probiotic use-2011 update.

  2011cited by this paper
• Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis.

  2009cited by this paper
• Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2

  2009cited by this paper
• Probiotic Prophylaxis in Predicted Severe Acute Pancreatitis: A Randomised, Double-Blind, Placebo-Controlled Trial.

  2008cited by this paper
• Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.

  2008cited by this paper
• Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.

  2008cited by this paper
• Intestinal flora, probiotics, and cirrhosis.

  2008cited by this paper
• Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis.

  2008cited by this paper
• Ammonia impairs neutrophil phagocytic function in liver disease

  2008cited by this paper
• Bacterial infections, sepsis, and multiorgan failure in cirrhosis.

  2008cited by this paper
• Endotoxin measures in patients' sample: how valid are the results?

  2007cited by this paper
• Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome

  2007cited by this paper
• The effect of probiotics on gut flora, level of endotoxin and Child–Pugh score in cirrhotic patients: results of a double-blind randomized study

  2007cited by this paper
• Supply of Pre‐ and Probiotics Reduces Bacterial Infection Rates After Liver Transplantation—A Randomized, Double‐Blind Trial

  2005cited by this paper
• Bacterial translocation (BT) in cirrhosis

  2005cited by this paper
• Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases

  2005cited by this paper
• Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis

  2004cited by this paper
• Influence of neopterin on generation of reactive species by myeloperoxidase in human neutrophils.

  2004cited by this paper
• Intestinal permeability is increased in patients with advanced cirrhosis.

  2003cited by this paper
• Potential role of immune system activation-associated production of neopterin derivatives in humans

  2003cited by this paper
• Bacterial translocation of enteric organisms in patients with cirrhosis.

  2001cited by this paper
• Neopterin: a review

  1999cited by this paper
• Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality.

  1997cited by this paper
• Global burden of disease.

  1997cited by this paper

• Study on the Association between Proton Pump Inhibitor and Onset of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis

  2026cites this paper
• A multi-strain probiotic modulates gut microbiome composition, intestinal barrier integrity and inflammation in a multi-compartmental in vitro gut model of decompensated alcohol-related advanced chronic liver disease.

  2026cites this paper
• Value of Probiotics on Outcome in Patients Following Liver Surgery: A Systematic Review and Meta-Analysis

  2025cites this paper
• Recurrent Clostridioides difficile Infection (CDI) in Patients Treated With Vancomycin at Johns Hopkins Aramco Healthcare (JHAH), Dhahran, Saudi Arabia

  2025cites this paper
• The role of gut microbiota in modulating immune responses in chronic liver disease: a systematic review and meta-analysis

  2025cites this paper
• The effect of probiotic supplementation on zonulin levels in healthy individuals – A systematic review and meta-analysis

  2025cites this paper
• The Effects of Probiotic Supplementation on Treatment Outcomes of Patients with Active Tuberculosis: A Systematic Review of Randomized Controlled Trials

  2025cites this paper
• Naturopathic Management to Taper Off Glucagon-Like Peptide-1 Receptor Agonist Therapy in Type 2 Diabetes: A Case Report.

  2025cites this paper
• The Effects of Prebiotic Dietary Fibers, Probiotics, and Synbiotics on Gut Permeability and Immunity: A Systematic Review

  2025influential citation
• An observational study on the effect of l-ornithine-l-aspartate (LOLA) on the gut microbiome in liver cirrhosis. A single center phase 4 study.

  2025cites this paper
• Cetobacterium somerae-derived argininosuccinic acid promotes intestinal and liver ureagenesis to alleviate ammonia intoxication

  2025cites this paper
• Probiotics for the Management of Liver Cirrhosis and Its Complications.

  2025cites this paper
• Primary sarcopenia is associated with elevated spontaneous NET formation

  2024cites this paper
• Exploring the Relationship between Liver Disease, Bacterial Translocation, and Dysbiosis: Unveiling the Gut-Liver Axis

  2024cites this paper
• Liver damage and immune responses

  2024influential citation
• Intestinal Barrier Impairment, Preservation, and Repair: An Update

  2024cites this paper
• Effect of Probiotics on Improving Intestinal Mucosal Permeability and Inflammation after Surgery

  2024cites this paper
• Clinical Implications of Inflammation in Patients With Cirrhosis

  2024cites this paper
• Efficacy of Probiotics on Improvement of Health Outcomes in Cirrhotic Liver Disease Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

  2024influential citation
• Effect of oral multispecies probiotic on wound healing, periodontitis and quality of life on patients with diabetes.

  2024cites this paper
• Probiotics are beneficial for liver cirrhosis: a systematic review and meta-analysis of randomized control trials

  2024cites this paper
• The Anti-Inflammatory and Curative Exponent of Probiotics: A Comprehensive and Authentic Ingredient for the Sustained Functioning of Major Human Organs

  2024cites this paper
• The role of neutrophils in alcohol-related hepatitis.

  2023cites this paper
• Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis

  2023cites this paper
• Effect of albumin infusion on oxidative albumin modification and albumin binding capacity in chronic liver failure

  2023cites this paper
• A REVIEW OF THE PHYTOCHEMICAL PROPERTIES AND PHARMACOLOGICAL USES OF THE GENUS PISTACIA L. (ANACARDIACEAE)

  2023influential citation
• Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?

  2023cites this paper
• LACTOBACILLI SPECIES’ EFFECTS ON LIVER FUNCTION: A REVIEW

  2023influential citation
• Consumer Studies Focus on Prebiotics, Probiotics, and Synbiotics in Food Packaging: a Review

  2023cites this paper
• Immune Biomarkers in Non-Treatment-Seeking Heavy Drinkers Who Used a Probiotic Supplement for 30 Days: An Open-Label Pilot Study.

  2023cites this paper
• Do gut microbiome‐targeted therapies improve liver function in cirrhotic patients? A systematic review and meta‐analysis

  2023influential citation
• Circulating neutrophil anti-pathogen dysfunction in cirrhosis

  2023influential citation
• Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review

  2023cites this paper
• Effect of probiotics therapy on intestinal leakage: A meta-analysis of randomized controlled trials

  2023cites this paper
• Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease

  2023cites this paper
• Anti-CD20 treatment and neutrophil function in central nervous system demyelinating diseases.

  2023cites this paper
• Fungal translocation measured by serum 1,3‐ß‐D‐glucan correlates with severity and outcome of liver cirrhosis—A pilot study

  2023cites this paper
• Direct and indirect effects of pathogenic bacteria on the integrity of intestinal barrier

  2023cites this paper
• Assessment of Intestinal Permeability and Inflammation Bio-Markers in Patients with Rheumatoid Arthritis

  2023cites this paper
• Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials

  2023cites this paper
• The shaping of gut immunity in cirrhosis

  2023cites this paper
• Potential therapies for acute‐on‐chronic liver failure

  2023cites this paper
• Des probiotiques pour l’encéphalopathie hépatique

  2022cites this paper
• Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potential

  2022cites this paper
• The potential role of adherence factors in probiotic function in the gastrointestinal tract of adults and pediatrics: a narrative review of experimental and human studies

  2022cites this paper
• Role of prebiotic and probiotic in gastrointestinal Disease

  2022cites this paper
• Association Between Proton Pump Inhibitor Therapy and Spontaneous Bacterial Peritonitis Occurrence in Cirrhotic Patients: A Clinical Review

  2022cites this paper
• Lactobacillus paracasei BD5115-Derived 2-Hydroxy-3-Methylbutyric Acid Promotes Intestinal Epithelial Cells Proliferation by Upregulating the MYC Signaling Pathway

  2022cites this paper
• Endotoxin Translocation and Gut Barrier Dysfunction Are Related to Variceal Bleeding in Patients With Liver Cirrhosis

  2022cites this paper
• Biopolymer‐Based Multilayer Microparticles for Probiotic Delivery to Colon

  2022cites this paper
• Influence of Probiotics Administration Before Liver Resection in Patients with Liver Disease: A Randomized Controlled Trial

  2021cites this paper
• The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy

  2021cites this paper
• Therapeutic modulation methods of gut microbiota and gut-liver axis

  2021cites this paper
• The Gut-Liver Axis in Cholestatic Liver Diseases

  2021cites this paper
• Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions

  2021cites this paper
• Kefir Is a Viable Exercise Recovery Beverage for Cancer Survivors Enrolled in a Structured Exercise Program

  2021cites this paper
• Potential Probiotic Lactobacillus Rhamnosus (MTCC-5897) Attenuates Escherichia Coli Induced Inflammatory Response in Intestinal Cells

  2021cites this paper
• Probiotic-Based Therapy for Active Tuberculosis Infection: The Role of Gut-Lung Axis and Granulocyte Macrophage-Colony Stimulating Factor

  2021cites this paper
• Microbiome Therapeutics for Hepatic Encephalopathy.

  2021cites this paper
• Alcohol’s Impact on the Gut and Liver

  2021cites this paper
• Probiotics in hepatology: An update

  2021cites this paper
• Cirrhosis-associated immune dysfunction

  2021cites this paper
• Implications and Management of Cirrhosis‐Associated Immune Dysfunction Before and After Liver Transplantation

  2021cites this paper
• Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer?

  2021cites this paper
• Potential probiotic Lacticaseibacillus rhamnosus MTCC-5897 attenuates Escherichia coli induced inflammatory response in intestinal cells

  2021cites this paper
• Direct acting antiviral therapy rescues neutrophil dysfunction and reduces hemolysis in hepatitis C infection.

  2020cites this paper
• Dysbiosis, gut barrier dysfunction and in�ammation in dementia: A pilot study

  2020cites this paper
• Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trials.

  2020cites this paper
• Effects of both Pro- and Synbiotics in Liver Surgery and Transplantation with Special Focus on the Gut–Liver Axis—A Systematic Review and Meta-Analysis

  2020cites this paper
• The Development of High-Quality Multispecies Probiotic Formulations: From Bench to Market

  2020cites this paper
• Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis

  2020cites this paper
• Interactions of dietary fat with the gut microbiota: Evaluation of mechanisms and metabolic consequences.

  2020cites this paper
• Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study

  2020cites this paper
• The Effects of Probiotic/Synbiotic on Serum Level of Zonulin as a Biomarker of Intestinal Permeability: A Systematic Review and Meta-Analysis

  2020cites this paper
• Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis

  2020cites this paper
• A Double-Blind, Randomized Placebo-Controlled Trial of Probiotic Lactobacillus casei Shirota in Stable Cirrhotic Patients

  2020cites this paper
• Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein.

  2020cites this paper
• Is Probiotic and Synbiotic Supplementation Effective on Immune Cells? A Systematic Review and Meta-analysis of Clinical Trials

  2020cites this paper
• The effects of a multispecies synbiotic on microbiome-related side effects of long-term proton pump inhibitor use: A pilot study

  2020cites this paper
• Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis

  2020cites this paper
• Post-hoc analysis of a randomized controlled trial on the impact of pre-transplant use of probiotics on outcomes after liver transplantation

  2020cites this paper
• The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage

  2020cites this paper
• Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut–Liver Axis: A Case Control Study

  2020cites this paper
• Tryptophan Metabolism and Related Pathways in Psychoneuroimmunology: The Impact of Nutrition and Lifestyle

  2019cites this paper
• Antimicrobial resistance in chronic liver disease

  2019cites this paper
• Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study

  2019cites this paper
• The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies

  2019cites this paper
• Population Pharmacokinetics of Voriconazole and Optimization of Dosage Regimens Based on Monte Carlo Simulation in Liver Cirrhosis Patients.

  2019cites this paper
• Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

  2019cites this paper
• Identification and characterization of lactic acid bacteria isolated from some medicinal and/or edible Philippine plants

  2019cites this paper
• Preparation and characterization of selenium enriched-Bifidobacterium longum DD98, and its repairing effects on antibiotic-induced intestinal dysbacteriosis in mice.

  2019cites this paper
• Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and 1 prescription drug use 2

  2019cites this paper
• The pros, cons, and many unknowns of probiotics

  2019cites this paper
• Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial

  2019cites this paper
• Mikrobiom bei Leberzirrhose: Pathophysiologie und therapeutische Interventionen

  2019cites this paper
• A single alcohol binge impacts on neutrophil function without changes in gut barrier function and gut microbiome composition in healthy volunteers

  2019cites this paper
• Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: A randomized, double-blind, placebo-controlled trial.

  2019cites this paper
• The impact of probiotics and n-3 long-chain polyunsaturated fatty acids on intestinal permeability in pregnancy: a randomised clinical trial.

  2018cites this paper
• A Systematic Review, Meta-Analysis, and Meta-Regression Evaluating the Efficacy and Mechanisms of Action of Probiotics and Synbiotics in the Prevention of Surgical Site Infections and Surgery-Related Complications

  2018cites this paper
• Migräneprophylaxe mit einem Probiotikum

  2018cites this paper